Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenyang Liu

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Thoracic Cancer|December 20, 2021
Development and validation of a prediction model using molecular marker for long-term survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapyYufan Yang, Tao Zhang, Zongmei Zhou, et al.
Clinical Medicine Insights. Oncology|March 7, 2022
Local Therapy Combined With First-Line EGFR Tyrosine Kinase Inhibitor Achieves Favorable Survival in Patients With EGFR-Mutant Metastatic Non-Small Cell Lung CancerXiaotong Lu, Jingbo Wang, Chunyu Wang, et al.
Med (New York, N.Y.)|June 9, 2026
Single-cell profiling unveils an exhaustion trajectory of ZNF683<sup>hi</sup> tissue-resident alveolar CD8<sup>+</sup> T cells in checkpoint inhibitor pneumonitisXiaoxiang Zhou, Ziming Jiang, Yanhong Ren, et al.
Cancers|October 14, 2022
A Single Center Analysis of Thymic Neuroendocrine TumorsYirui Zhai, Qiang Zeng, Nan Bi, et al.
Radiation Oncology (London, England)|March 29, 2022
Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminomaYirui Zhai, Bo Chen, Xiaoli Feng, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|November 21, 2024
Integrated analysis and systematic characterization of the regulatory network for human germline developmentYashi Gu, Jiayao Chen, Ziqi Wang, et al.
Therapeutic Advances in Medical Oncology|February 16, 2026
The role of thoracic radiotherapy in the setting of immunotherapy in polymetastatic esophageal squamous cell carcinoma: a multi-center cohort studyQi Liu, Junqiang Chen, Wenbin Shen, et al.
Therapeutic Advances in Medical Oncology|November 20, 2024
Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter studyYu Lin, Wenbin Shen, Jinjun Ye, et al.
Signal Transduction and Targeted Therapy|January 19, 2026
Correction: Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patientsYin Yang, Yuqi Wu, Jingjing Zhao, et al.
Signal Transduction and Targeted Therapy|October 15, 2025
Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patientsYin Yang, Yuqi Wu, Jingjing Zhao, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Thoracic Cancer|December 20, 2021
Development and validation of a prediction model using molecular marker for long-term survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapyYufan Yang, Tao Zhang, Zongmei Zhou, et al.
Clinical Medicine Insights. Oncology|March 7, 2022
Local Therapy Combined With First-Line EGFR Tyrosine Kinase Inhibitor Achieves Favorable Survival in Patients With EGFR-Mutant Metastatic Non-Small Cell Lung CancerXiaotong Lu, Jingbo Wang, Chunyu Wang, et al.
Med (New York, N.Y.)|June 9, 2026
Single-cell profiling unveils an exhaustion trajectory of ZNF683<sup>hi</sup> tissue-resident alveolar CD8<sup>+</sup> T cells in checkpoint inhibitor pneumonitisXiaoxiang Zhou, Ziming Jiang, Yanhong Ren, et al.
Cancers|October 14, 2022
A Single Center Analysis of Thymic Neuroendocrine TumorsYirui Zhai, Qiang Zeng, Nan Bi, et al.
Radiation Oncology (London, England)|March 29, 2022
Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminomaYirui Zhai, Bo Chen, Xiaoli Feng, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|November 21, 2024
Integrated analysis and systematic characterization of the regulatory network for human germline developmentYashi Gu, Jiayao Chen, Ziqi Wang, et al.
Therapeutic Advances in Medical Oncology|February 16, 2026
The role of thoracic radiotherapy in the setting of immunotherapy in polymetastatic esophageal squamous cell carcinoma: a multi-center cohort studyQi Liu, Junqiang Chen, Wenbin Shen, et al.
Therapeutic Advances in Medical Oncology|November 20, 2024
Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter studyYu Lin, Wenbin Shen, Jinjun Ye, et al.
Signal Transduction and Targeted Therapy|January 19, 2026
Correction: Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patientsYin Yang, Yuqi Wu, Jingjing Zhao, et al.
Signal Transduction and Targeted Therapy|October 15, 2025
Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patientsYin Yang, Yuqi Wu, Jingjing Zhao, et al.
Pageof 8